Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Early hair loss may indicate future prostate issues.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Urinary PSA could be an early marker for enlarged prostate.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

No definitive link between finasteride and male breast cancer, but further research is needed.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

Herbal treatments can help with early-stage BPH symptoms, but more research is needed.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Hair loss gene linked to prostate issues.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Finasteride does not prevent bladder cancer.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.